Variant report
Variant | rs2240919 |
---|---|
Chromosome Location | chr3:52831701-52831702 |
allele | C/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr3:52802780..52807602-chr3:52827391..52831755,5 | K562 | blood: | |
2 | chr3:52819022..52821940-chr3:52830532..52832899,2 | K562 | blood: | |
3 | chr3:52831117..52833454-chr3:52835406..52839409,3 | K562 | blood: | |
4 | chr3:52831402..52833454-chr3:52836536..52839409,2 | K562 | blood: | |
5 | chr3:52719608..52722839-chr3:52830545..52833712,3 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ITIH3 | TF binding region |
ENSG00000163939 | Chromatin interaction |
ENSG00000055957 | Chromatin interaction |
ENSG00000162267 | Chromatin interaction |
ENSG00000163938 | Chromatin interaction |
ENSG00000114904 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs1014969 | 0.86[JPT][hapmap] |
rs1029871 | 0.86[JPT][hapmap] |
rs1042779 | 0.91[CHB][hapmap];0.90[JPT][hapmap];0.88[ASN][1000 genomes] |
rs10510760 | 0.86[JPT][hapmap] |
rs1075653 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs1076425 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.84[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs10780035 | 0.86[JPT][hapmap] |
rs10865973 | 0.86[JPT][hapmap] |
rs10865974 | 0.86[JPT][hapmap] |
rs11130310 | 0.85[JPT][hapmap] |
rs11130312 | 0.86[JPT][hapmap] |
rs11130315 | 0.86[JPT][hapmap] |
rs11130317 | 0.86[JPT][hapmap] |
rs11130323 | 0.86[JPT][hapmap] |
rs11177 | 0.81[JPT][hapmap] |
rs11716747 | 0.86[JPT][hapmap] |
rs11717836 | 0.85[JPT][hapmap] |
rs12487591 | 0.86[JPT][hapmap] |
rs12488461 | 0.85[JPT][hapmap] |
rs12496634 | 0.86[JPT][hapmap] |
rs12497998 | 0.86[JPT][hapmap] |
rs12635140 | 0.86[JPT][hapmap] |
rs13064064 | 0.86[JPT][hapmap] |
rs13068293 | 0.86[JPT][hapmap] |
rs13071584 | 0.86[JPT][hapmap] |
rs13079063 | 0.90[JPT][hapmap] |
rs13082208 | 0.89[JPT][hapmap] |
rs13082960 | 0.85[JPT][hapmap] |
rs13083798 | 0.81[JPT][hapmap] |
rs13085895 | 0.86[JPT][hapmap] |
rs1561337 | 0.86[JPT][hapmap] |
rs1866268 | 0.86[JPT][hapmap] |
rs2019065 | 0.91[CHB][hapmap];0.95[JPT][hapmap];0.87[ASN][1000 genomes] |
rs2028216 | 0.86[JPT][hapmap] |
rs2071506 | 0.91[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2071507 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.85[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs2071508 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.84[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs2072390 | 0.85[JPT][hapmap] |
rs2079929 | 0.86[JPT][hapmap] |
rs2083180 | 0.86[JPT][hapmap] |
rs2159644 | 0.86[JPT][hapmap] |
rs2164885 | 0.90[JPT][hapmap] |
rs2230535 | 0.86[JPT][hapmap] |
rs2239549 | 0.91[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2239550 | 0.92[ASN][1000 genomes] |
rs2239551 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2239699 | 1.00[CHB][hapmap];0.89[JPT][hapmap];0.85[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs2240920 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.82[AMR][1000 genomes];0.98[ASN][1000 genomes] |
rs2268023 | 0.96[CHB][hapmap];0.91[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2268025 | 0.87[JPT][hapmap] |
rs2268026 | 0.86[JPT][hapmap] |
rs2268027 | 0.85[JPT][hapmap] |
rs2270197 | 0.96[CHB][hapmap];0.91[JPT][hapmap];0.87[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs2284350 | 0.84[ASN][1000 genomes] |
rs2284351 | 0.82[ASN][1000 genomes] |
rs2286798 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes] |
rs2289247 | 0.86[JPT][hapmap] |
rs2289250 | 0.86[JPT][hapmap] |
rs2300149 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs2336149 | 0.86[JPT][hapmap] |
rs2336545 | 0.86[JPT][hapmap] |
rs2535629 | 0.91[CHB][hapmap];0.86[JPT][hapmap];0.84[ASN][1000 genomes] |
rs2710323 | 0.87[CHB][hapmap];0.81[JPT][hapmap] |
rs2710331 | 0.86[ASN][1000 genomes] |
rs33967311 | 0.86[JPT][hapmap] |
rs34017441 | 0.90[JPT][hapmap] |
rs35526119 | 0.86[JPT][hapmap] |
rs3617 | 0.83[CHB][hapmap];0.81[JPT][hapmap] |
rs3733039 | 0.86[JPT][hapmap] |
rs3733041 | 0.86[JPT][hapmap] |
rs3733045 | 0.86[JPT][hapmap] |
rs3755798 | 0.86[JPT][hapmap] |
rs3755806 | 0.86[JPT][hapmap] |
rs3774354 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs3774355 | 0.96[CHB][hapmap];0.87[JPT][hapmap];0.92[ASN][1000 genomes] |
rs3774365 | 0.86[JPT][hapmap] |
rs3774366 | 0.86[JPT][hapmap] |
rs4687548 | 0.86[JPT][hapmap] |
rs4687550 | 0.96[CHB][hapmap];0.91[JPT][hapmap] |
rs4687551 | 0.95[CHB][hapmap];0.86[JPT][hapmap];0.80[AMR][1000 genomes];0.89[ASN][1000 genomes] |
rs4687552 | 0.81[AMR][1000 genomes];0.86[ASN][1000 genomes] |
rs4687638 | 0.86[JPT][hapmap] |
rs4687654 | 0.84[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs6445534 | 0.82[JPT][hapmap] |
rs6445535 | 0.86[JPT][hapmap] |
rs6617 | 0.86[JPT][hapmap] |
rs6762813 | 0.86[JPT][hapmap] |
rs6778329 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.83[AMR][1000 genomes];0.96[ASN][1000 genomes] |
rs678 | 1.00[CHB][hapmap];0.95[JPT][hapmap];0.96[ASN][1000 genomes] |
rs6792369 | 0.87[ASN][1000 genomes] |
rs6804145 | 0.86[JPT][hapmap] |
rs6976 | 0.86[JPT][hapmap] |
rs736408 | 0.88[CHB][hapmap];0.82[JPT][hapmap] |
rs746694 | 0.80[AMR][1000 genomes];0.95[ASN][1000 genomes] |
rs7611731 | 0.86[JPT][hapmap] |
rs7622694 | 0.86[JPT][hapmap] |
rs7624716 | 0.86[JPT][hapmap] |
rs767418 | 0.85[JPT][hapmap] |
rs8906 | 0.86[JPT][hapmap] |
rs9324 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.92[ASN][1000 genomes] |
rs9881468 | 0.95[CHB][hapmap];0.90[JPT][hapmap];0.83[AMR][1000 genomes];0.92[ASN][1000 genomes] |
rs998909 | 0.90[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv984563 | chr3:52516115-52867075 | Weak transcription Strong transcription Enhancers Active TSS Flanking Active TSS Genic enhancers ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' Flanking Bivalent TSS/Enh Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 63 gene(s) | inside rSNPs | diseases |
2 | nsv834698 | chr3:52749983-52928219 | Weak transcription Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Strong transcription ZNF genes & repeats Active TSS Genic enhancers Bivalent Enhancer Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA | 27 gene(s) | inside rSNPs | diseases |
3 | esv2762328 | chr3:52774884-53002150 | Strong transcription Enhancers Active TSS Flanking Active TSS Weak transcription Genic enhancers Bivalent Enhancer Transcr. at gene 5' and 3' ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
4 | esv3446915 | chr3:52786850-53049217 | Strong transcription Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers Genic enhancers ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNAmiRNA target site | 27 gene(s) | inside rSNPs | diseases |
5 | nsv1010761 | chr3:52804547-52851258 | Enhancers Weak transcription Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Strong transcription ZNF genes & repeats Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
6 | esv1810629 | chr3:52817031-52869635 | Weak transcription Active TSS Strong transcription Bivalent Enhancer Enhancers Flanking Active TSS ZNF genes & repeats Flanking Bivalent TSS/Enh Genic enhancers Transcr. at gene 5' and 3' Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
7 | nsv876797 | chr3:52817675-52873984 | Weak transcription Enhancers Strong transcription Genic enhancers Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' Flanking Active TSS Flanking Bivalent TSS/Enh ZNF genes & repeats Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 16 gene(s) | inside rSNPs | diseases |
SNP | Gene | Cis/trans | Tissue | Source |
---|---|---|---|---|
rs2240919 | ITIH4-AS1 | cis | Artery Aorta | GTEx |
rs2240919 | NT5DC2 | cis | Skin Sun Exposed Lower leg | GTEx |
rs2240919 | ITIH4-AS1 | cis | Artery Tibial | GTEx |
rs2240919 | GLT8D1 | Cis_1M | lymphoblastoid | RTeQTL |
rs2240919 | NT5DC2 | Cis_1M | lymphoblastoid | RTeQTL |
rs2240919 | FLJ12442 | cis | multi-tissue | Pritchard |
rs2240919 | NT5DC2 | cis | multi-tissue | Pritchard |
rs2240919 | PBRM1 | cis | Thyroid | GTEx |
rs2240919 | MUSTN1 | cis | Artery Aorta | GTEx |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:52824000-52832800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr3:52825800-52836200 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr3:52827800-52832000 | Weak transcription | HSMM | muscle |
4 | chr3:52828200-52835800 | Weak transcription | HSMMtube | muscle |
5 | chr3:52828600-52832600 | Weak transcription | Stomach Mucosa | stomach |
6 | chr3:52829000-52832200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
7 | chr3:52829000-52832400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
8 | chr3:52829000-52834200 | Weak transcription | Brain Substantia Nigra | brain |
9 | chr3:52829600-52832400 | Weak transcription | Placenta | Placenta |
10 | chr3:52830200-52832000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
11 | chr3:52830200-52833200 | Weak transcription | Fetal Thymus | thymus |
12 | chr3:52830400-52832600 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
13 | chr3:52830400-52834000 | Genic enhancers | HepG2 | liver |
14 | chr3:52830400-52836400 | Weak transcription | Pancreas | Pancrea |
15 | chr3:52830600-52832000 | Weak transcription | Spleen | Spleen |
16 | chr3:52830800-52835000 | Genic enhancers | Liver | Liver |